{"id":"nct:NCT05055908","kind":"trial","title":"Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors","authors":["Hunan Province Tumor Hospital"],"author_count":1,"year":2021,"published":"2021-09-24","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT05055908","source_url":"https://clinicaltrials.gov/study/NCT05055908","archive_url":"https://space-kitty.com/papers/nct:NCT05055908","updated":"2024-08-02","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"The purpose of the study is to find some biomarkers to predict the the adverse events of Immune Checkpoint Inhibitors monotherapy or plus platinum based chemotherapy in lung cancer.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lung Cancer"],"details":{"acronym":"BECOME","status":"RECRUITING","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":12000,"sponsor":"Hunan Province Tumor Hospital","conditions":["Lung Cancer"],"interventions":["DRUG: Pemetrexed plus Pembrolizumab","DRUG: Pembrolizumab","DRUG: Pemetrexed"],"start_date":"2021-10-01","start_date_type":"ACTUAL","primary_completion_date":"2025-07-01","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}